IL7 and COVID-19: The elevation of IL-7, granulocyte-macrophage colony stimulating factor, interferon-gamma (IFN-γ), and fibroblast growth factor in COVID-19 patients might be involved in the development of AKI in COVID-19 patients and induced endothelial cell and tubular dysfunction [40].